Site search
2863 results for '' found
Sonika Parakash
/about/bio/sonika-parakash
Grace Beaton
/about/bio/grace-beaton
Aimee Neylan
/about/bio/aimee-neylan
Margeret Quayle
/about/bio/margeret-quayle
A/Prof Tim Coulson
/about/bio/a-prof-tim-coulson
Alfred_Health_GP_News_-_November_2025.pdf
Client_contribution_-_CHSP.pdf
A Phase 3 Study Comparing Daratumumab, VELCADE [bortezomib], Lenalidomide, and Dexamethasone [D-VRd] vs VELCADE, Lenalidomide, and Dexamethasone [VRd] in Subjects with Previously Untreated Multip
A Phase 3 Study Comparing Daratumumab, VELCADE [bortezomib], Lenalidomide, and Dexamethasone [D-VRd] vs VELCADE, Lenalidomide, and Dexamethasone [VRd] in Subjects with Previously Untreated Multip
/
A Phase 1, Open-Label, Multicenter Study of INCA035784 in Participants With Myeloproliferative Neoplasms (NCT07008118)
A Phase 1, Open-Label, Multicenter Study of INCA035784 in Participants With Myeloproliferative Neoplasms (NCT07008118)
/
A Phase 2, randomized, open-label, controlled study to evaluate the efficacy and safety of rapcabtagene autoleucel versus comparator in participants with severe refractory idiopathic inflammatory
A Phase 2, randomized, open-label, controlled study to evaluate the efficacy and safety of rapcabtagene autoleucel versus comparator in participants with severe refractory idiopathic inflammatory
/